Osteoporosis is one of the major bone disorders that affects both women and men, and
causes bone deterioration and bone strength. Bone remodeling maintains bone mass and …

Senescence mainly manifests as a series of degenerative changes in the morphological
structure and function of the body. Osteoporosis is a systemic bone metabolic disease …

Osteoporosis (OP) is a bone metabolic disease, is characterized by degeneration of bone
structure and decreased bone mass. It happens in more than 1/3 women and 1/5 men of …

Tissue-engineered graft substitutes have shown great potential to treat large bone defects.
While we usually assume that therapeutic approaches developed for appendicular bone …

Osteoporosis (OP) is the most prevalent metabolic bone disease, characterized by the low
bone mass and microarchitectural deterioration of bone tissue. Glucocorticoid (GC) clinically …

Antiresorptive drugs have been widely used for osteoporosis. Intermittent parathyroid
hormone (PTH), an anabolic agent, increases osteoblast production rate and inhibits …

Almost all patients with chronic liver diseases (CLD) show altered bone metabolism.
Depending on the etiology, this manifests in a severe osteoporosis in up to 75% of the …

Metabolic bone diseases are serious health issues worldwide, since several million
individuals over the age of 50 are at risk of bone damage and should be worried about their …

Excessive bone resorption by osteoclasts (OCs) covers an essential role in developing bone
diseases, such as osteoporosis (OP) and rheumatoid arthritis (RA). Monocytes or …

Abstract Purpose of Review Inflammasomes are multimeric protein structures with crucial
roles in host responses against infections and injuries. The importance of inflammasome …